These recommendations are based on studies demonstrating a higher risk of flare in patients who are 1) lowering the dose of a DMARD versus continuing DMARDs at the same dose, and 2) abruptly versus gradually discontinuing a DMARD Gradual discontinuation of sulfasalazine is conditionally recommended over gradual discontinuation of hydroxychloroquine for patients taking triple therapy who wish to discontinue a DMARD Gradually discontinuing sulfasalazine is recommended because of its poorer